Ubs Oconnor LLC Autolus Therapeutics PLC Transaction History

Ubs Oconnor LLC

$2.23 Billion
Q2 2025

A detailed history of Ubs Oconnor LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Ubs Oconnor LLC holds 565,000 shares of AUTL stock, worth $926,600. This represents 0.06% of its overall portfolio holdings.

Number of Shares

565,000

Holding current value

$926,600

% of portfolio

0.06%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.14 - $2.4 $644,100 - $1.36 Million	565,000 New	565,000 $1.29 Million
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $2.06 Million - $2.79 Million	-382,909 Reduced 71.07%	155,857 $994,000
Q4 2023 Feb 14, 2024	SELL	$2.13 - $6.63 $100,435 - $312,624	-47,153 Reduced 8.05%	538,766 $3.47 Million
Q3 2023 Nov 14, 2023	BUY	$2.32 - $3.36 $127,599 - $184,800	55,000 Added 10.36%	585,919 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$1.64 - $3.21 $870,707 - $1.7 Million	530,919 New	530,919 $1.26 Billion
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $63,084 - $81,108	36,048 Added 5.0%	757,008 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $237,603 - $446,531	136,554 Added 23.37%	720,960 $0
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.76 $326 - $601	160 Added 0.03%	584,406 $1.25 Billion
Q2 2022 Aug 12, 2022	BUY	$2.04 - $4.68 $783,861 - $1.8 Million	384,246 Added 192.12%	584,246 $1.65 Million
Q1 2022 May 16, 2022	BUY	$3.52 - $5.46 $704,000 - $1.09 Million	200,000 New	200,000 $834,000

Others Institutions Holding AUTL

# of Institutions

100

Shares Held

164M

Call Options Held

Put Options Held

39.3K

Wellington Management Group LLP Boston, MA

27.1M
Shares

$44.5 Million
0.01% of portfolio
Blackstone Inc New York, NY

20.5M
Shares

$33.6 Million
0.22% of portfolio
Mak Capital One LLC New York, NY

17M
Shares

$27.8 Million
5.54% of portfolio
Deep Track Capital, LP Greenwich, CT

16.9M
Shares

$27.6 Million
1.36% of portfolio
Syncona Portfolio LTD Guernsey, Channel Islands, X0

16.6M
Shares

$27.3 Million
98.24% of portfolio

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $149M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account